Analgesic efficacy of the oblique subcostal transverse abdominis plane block in the surgical repair of large abdominal wall hernias

Phase 4

• Conditions: K43; Ventral hernia

• Registration Number: DRKS00030592
• Lead Sponsor: Klinik für Anästhesie und Intensivmedizin Diakonie-Klinikum Stuttgart

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-10-25
• Study Completion: 2023-12-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

• Presence of an abdominal wall hernia which is to be treated surgically by means of an open hernioplasty using the sublay technique
• Consentable patient
• Age > 18 years
• Provided information and consent

Exclusion Criteria

• Refusal to participate in the study
• Regular use of opioids
• Known chronic pain symptoms
• Infections in the abdominal wall
• Scarring changes in the abdominal wall that could prevent intrafascial spread of the local anesthetic
• Pregnancy
• Presence of a contraindication to ropivacaine

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint is the postoperative consumption of intravenously administered morphine during the first 48 hours after surgery. This is quantified using patient-controlled analgesia using specialized syringe pumps.

Secondary Outcome Measures

Name	Time	Method
Secondary Endpoints:<br>- NRS values on the evening of the operation, in the morning and evening of the first and second postoperative day<br>- PONV score on the evening of the operation, in the morning and evening of the first and second postoperative day (subjective scale 0-3)<br>- Postoperative length of stay in the recovery room in minutes<br>- postoperative length of stay in hospital in days<br>- overall satisfaction on the evening of the operation, in the morning and evening of the first and second postoperative day (subjective scale 0-10)